Uzm. Dr. Özge Soyer Kösemehmetoğlu

2026 Myeloma Treatment Guidelines of the Turkish Myeloma Study Group

Clinical Lymphoma Myeloma and Leukemia, 2026

DOI 10.1016/j.clml.2026.08.008 PMID 42705998 Source: ORCID

Real-world data of extended half-life factor VIII prophylaxis in patients with hemophilia A: A multicenter retrospective cohort study

Thrombosis Research, 2026

DOI 10.1016/j.thromres.2026.109871 PMID 42901012 Source: ORCID

Edinsel Hemofili A’ya Klinik Yaklaşım: Bir Olgu Üzerinden Tanı ve Yönetim

Akademisyen Kitabevi eBooks, 2026

DOI 10.37609/akya.4308.c19897 Source: ORCID

Olgular Eşliğinde Erişkin Hematoloji

Akademisyen Kitabevi eBooks, 2026

DOI 10.37609/akya.4308 Open-access full textSource: OpenAlex

Real-Life Retrospective Turkiye Data of the De-Escalation of ABVD to AVD in Hodgkin Lymphoma: On Behalf of the TSH Turkish Lymphoma Study Group

Journal of Clinical Medicine, 2025

DOI 10.3390/jcm14196813 PMID 41095893 Open-access full textSource: OpenAlex

Arterial Thrombosis in Patients with Primary Immune Thrombocytopenia: A Nationwide Study

Turkish journal of haematology : official journal of Turkish Society of Haematology, 2025

DOI 10.4274/tjh.galenos.2025.2025.0268 PMID 40859646 1 citation (Europe PMC) Open-access full textSource: Europe PMC

Hemoglobin levels for the diagnosis of polycythemia vera: How high is high enough?

European Journal of Internal Medicine, 2025

DOI 10.1016/j.ejim.2025.02.018 PMID 39966046 1 citation (OpenAlex) Source: OpenAlex

Subklinik Tiroid Hastalarında Metabolik Sendrom Sıklığı

Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi, 2025

DOI 10.17517/ksutfd.1466604 Open-access full textSource: ORCID

Real-world outcomes and prognostic factors in primary mediastinal B-cell lymphoma: a multicenter study of 157 patients

Annals of Hematology, 2025

DOI 10.1007/s00277-025-06644-z PMID 41074982 2 citations (OpenAlex) Open-access full textSource: OpenAlex

INTERVENTIONAL PROCEDURE IN HEMOPHILIA A PATIENT WITH EXTENDED HALF-LIFE FACTOR THERAPY- CIRCUMCISION- CASE REPORT

Hematology Transfusion and Cell Therapy, 2024

DOI 10.1016/j.htct.2024.11.044 Open-access full textSource: OpenAlex

BEVACİZUMAB İLE MÜKEMMEL YANIT MÜMKÜN MÜ?

AYBU AVESIS, 2024

Source: OpenAlex

Comparison of different intravenous iron preparations in terms of total oxidant and total antioxidant status, single center data

Annals of Hematology, 2023

DOI 10.1007/s00277-023-05344-w PMID 37432415 Source: ORCID

DAMAR YOLUYLA UYGULANAN FARKLI DEMİR TEDAVİLERİNİN TOPLAM OKSİDAN VE ANTİOKSİDAN YÜK ÜZERİNE ETKİSİNİN KARŞILAŞTIRILMASI, TEK MERKEZ VERİSİ

AYBU AVESIS, 2023

Source: OpenAlex

Immune-Mediated Thrombotic Thrombocytopenic Purpura after BNT162b2 Vaccine

Turkish journal of haematology : official journal of Turkish Society of Haematology, 2022

DOI 10.4274/tjh.galenos.2021.2021.0537 PMID 34886748 4 citations (Europe PMC) Open-access full textSource: Europe PMC

Combination therapy with azacitidine, etoposide, and cytarabine in the treatment of elderly acute myeloid leukemia patients: A single center experience

Journal of Cancer Research and Therapeutics, 2018

DOI 10.4103/0973-1482.187369 PMID 30197357 5 citations (OpenAlex) Open-access full textSource: OpenAlex

The Predictive Role of the Neutrophil/Lymphocyte Ratio in Survival with Multiple Myeloma: A Single Center Experience

Journal of Clinical Laboratory Analysis, 2016

DOI 10.1002/jcla.22032 PMID 27500465 23 citations (OpenAlex) Open-access full textSource: OpenAlex

Comparative Evaluation of Common Comorbidity Scores and Freiburger Comorbidity Index as Prognostic Variables in a Real Life Multiple Myeloma Population

Indian Journal of Hematology and Blood Transfusion, 2015

DOI 10.1007/s12288-015-0618-y PMID 27812251 5 citations (OpenAlex) Open-access full textSource: OpenAlex